What is the recommended dose of Levaquin (levofloxacin) for a skin abscess caused by Staphylococcus aureus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levofloxacin is NOT Recommended for Skin Abscesses Caused by Staphylococcus aureus

Levofloxacin (Levaquin) should not be used as first-line therapy for skin abscesses caused by Staphylococcus aureus, as it is not included in any major guideline recommendations for this indication and lacks adequate anti-staphylococcal activity for purulent skin infections. 1

Why Levofloxacin is Inappropriate for Staph Aureus Skin Abscesses

Guideline-Recommended Agents for Skin Abscesses

The 2014 IDSA guidelines for skin and soft tissue infections specifically recommend the following for purulent infections (abscesses) caused by S. aureus 1:

For simple abscesses:

  • Incision and drainage alone is often sufficient (85-90% cure rates without antibiotics) 1
  • When antibiotics are indicated, use agents active against MRSA 1

Oral antibiotic options when needed:

  • TMP-SMX: 1-2 double-strength tablets twice daily 1
  • Doxycycline or minocycline: 100 mg twice daily 1
  • Clindamycin: 300-450 mg every 6-8 hours (only if local MRSA resistance <10%) 1, 2
  • Linezolid: 600 mg twice daily 1

For complicated/severe infections requiring IV therapy:

  • Vancomycin: 15 mg/kg every 8-12 hours 1
  • Linezolid: 600 mg IV every 12 hours 1
  • Daptomycin: 4 mg/kg IV daily 1
  • Ceftaroline: 600 mg IV twice daily 1

Why Fluoroquinolones Are Not Listed

Levofloxacin and other fluoroquinolones are conspicuously absent from guideline recommendations for staphylococcal skin abscesses because 1:

  • Inadequate anti-MRSA activity: Community-acquired MRSA is now the predominant pathogen in purulent skin infections, and fluoroquinolones have poor activity against MRSA 1
  • Variable activity against MSSA: Even for methicillin-susceptible S. aureus, fluoroquinolones are not optimal choices 1
  • Resistance concerns: Using fluoroquinolones for infections where better alternatives exist promotes unnecessary resistance 3

The Correct Approach to Staph Aureus Skin Abscesses

Step 1: Incision and Drainage

  • Primary treatment is surgical drainage 1, 2
  • For simple abscesses <5 cm without surrounding cellulitis, drainage alone achieves 85-90% cure rates 1, 2

Step 2: Determine if Antibiotics Are Needed

Antibiotics ARE indicated when: 1

  • Multiple abscesses present
  • Extensive surrounding cellulitis (>5 cm)
  • Systemic signs of infection (fever, tachycardia)
  • Immunocompromised host
  • Extremes of age
  • Lack of response to drainage alone
  • Difficult drainage location (face, hands, genitalia)

Step 3: Choose Appropriate Antibiotic

For outpatient oral therapy (5-10 days): 1, 2

  • TMP-SMX 1-2 double-strength tablets twice daily (preferred for most cases)
  • Doxycycline 100 mg twice daily (alternative)
  • Clindamycin 300-450 mg every 6-8 hours (if local MRSA clindamycin resistance <10%)

For hospitalized patients requiring IV therapy (7-14 days): 1

  • Vancomycin 15 mg/kg IV every 8-12 hours (first-line)
  • Linezolid 600 mg IV every 12 hours (alternative)
  • Daptomycin 4 mg/kg IV daily (alternative)

When Levofloxacin IS Appropriate

Levofloxacin 750 mg daily for 7-14 days is FDA-approved and guideline-recommended for complicated skin and skin structure infections when the pathogen spectrum includes gram-negative organisms 4, but this is distinctly different from simple staphylococcal abscesses. The FDA label shows 84% success rates in complicated skin infections, but these studies included mixed infections requiring broad-spectrum coverage 4.

Critical Pitfalls to Avoid

  • Do not use fluoroquinolones as empiric therapy for purulent skin infections in the current era of CA-MRSA predominance 1
  • Do not prescribe antibiotics without adequate drainage for abscesses—this is the most common cause of treatment failure 1, 2
  • Do not assume all skin infections are the same—purulent (abscess) and non-purulent (cellulitis) infections require different antibiotic approaches 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Clindamycin Dosing for Skin and Soft Tissue Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.